- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Phreesia Inc (PHR)
The Phreesia share price today is 10.35, view NYSE PHR stock exchange data. Track the latest Phreesia share price with real-time updates on PHR stock performance including market cap, day range, 52-week range and dividend yield. Access PHR charts, earnings dates and analyst estimates to support your investment decisions.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.22
10.51
52 wk Range
7.77
25.00
PHR is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.2210.51
52 wk Range
7.7725.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
PHR Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
13.94
Upside
+34.66%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
5 analysts have revised their earnings upwards for the upcoming period
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy
Analyst Ratings
10 Buy
9 Hold
0 Sell
Ratings:
19 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 13.94
(+34.66% Upside)
Phreesia Inc SWOT Analysis
Digital Health Pionee | Explore Phreesia's multifaceted platform revolutionizing patient engagement, administrative efficiency, and pharmaceutical marketing in the evolving healthcare IT landscape |
Financial Momentum | Delve into Phreesia's impressive revenue growth, improving profitability metrics, and transition to positive adjusted EBITDA and free cash flow generation |
Strategic Expansion | Learn how Phreesia's partnerships with large specialty provider networks and diverse revenue streams are driving scalability and market penetration |
Market Outlook | Analyst price targets range from $34 to $35, reflecting confidence in Phreesia's growth potential and its positioning as a "growth-at-a-reasonable-price" opportunity |
Phreesia Inc Earnings Call Summary for Q2/2027
- Phreesia reported Q2 revenue of $129.5M (up 10% YoY), beating estimates, but adjusted EPS of $0.03 missed forecasts by 66.7%, triggering a 7.59% after-hours drop.
- Adjusted EBITDA rose to $32.9M with 25% margin; company posted ninth consecutive quarter of positive operating and free cash flow, with net income at $1.9M.
- Management maintained FY2027 guidance of $510M-$520M revenue and $125M-$135M adjusted EBITDA, citing disciplined spending and revenue mix uncertainty.
- AccessOne acquisition contributing $37M in revenue; company expects mid-single-digit client growth and investing in AI tools like VoiceAI and PlanMatch.
- Healthcare services clients grew to 4,744 (up 277 YoY); sequential revenue dip attributed to seasonal payment processing decline after Q1 deductible resets.
Last Updated: 03-09-2026, 03:12 am
Read Full TranscriptEarnings
Latest Release
02-09-2026
EPS / Forecast
0.03 / 0.09
Revenue / Forecast
129.45M / 129.05M
Compare PHR to Peers and Sector
Metrics to compare | PHR | Sector Sector - Average of metrics from a broad group of related Technology sector companies | Relationship RelationshipPHRPeersSector | |
|---|---|---|---|---|
P/E Ratio | 61.5x | 12.3x | −0.4x | |
PEG Ratio | 0.44 | 0.05 | 0.00 | |
Price/Book | 1.7x | 2.4x | 2.6x | |
Price / LTM Sales | 1.3x | 1.4x | 3.0x | |
Upside (Analyst Target) | 29.6% | 19.2% | 54.5% | |
Fair Value Upside | Unlock | 39.9% | 7.8% | Unlock |
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. It offers solutions including appointment optimization and referral management using AI-enabled workflows; and AI-based smart answering solution patient communications supported by voice and messaging solutions; integrated payment solutions embedded in intake and post-visit workflows, and financing solutions that enable healthcare organizations to accelerate cash collections while offering flexible payment options to patients; and digital intake and clinical data capture, patient engagement and activation tools, and measurement and analytics solutions. It also offers PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, which are on-site kiosks. The company serves a range of healthcare organizations including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest and not-for-profit and other organizations. Phreesia, Inc. was incorporated in 2005 and is based in Wilmington, Delaware.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Phreesia (PHR) Share Price Today?
The Phreesia share price today is 10.35.
What is the current Phreesia (PHR) share price and day range?
As of 15-09-2026, the Phreesia share price is 10.35, with a previous close of 10.42. The share price has ranged from 10.22 to 10.51 today, while the 52-week range spans from 7.77 to 25.00.
What Is the Phreesia Market Cap?
As of today, Phreesia market cap is 641.19M.
What Is the Phreesia (PHR) Share Price Target?
The average 12-month share price target for Phreesia is 13.94, with a high estimate of 20 and a low estimate of 10. 10 analysts recommend buying, while 0 suggest selling, with an overall rating of Buy and +34.66% Upside potential.
What Is Phreesia's Earnings Per Share (TTM)?
The Phreesia EPS (TTM) is 0.17.
When Is the Next Phreesia Earnings Date?
Phreesia will release its next earnings report on 14-12-2026.
From a Technical Analysis Perspective, Is PHR a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does Phreesia Trade On?
Phreesia is listed and trades on the New York Stock Exchange.
What Is the Stock Symbol for Phreesia?
The stock symbol for Phreesia is "PHR."
How Many Times Has Phreesia Stock Split?
Phreesia has split 0 times.
How Many Employees Does Phreesia Have?
Phreesia has 1789 employees.
What Is the PHR Premarket Price?
PHR's last pre-market stock price is 10.43. The pre-market share volume is 1,060.00, and the stock has changed by 0.01, or 0.10%.
What Is the PHR After Hours Price?
PHR's last after hours stock price is 10.35, the stock has changed by -0.06, or -0.58%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.